• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃肠病学家和其他医疗保健专业人员对益生菌处方的见解:来自一项意大利调查的证据。

Insights into Probiotic Prescription among Gastroenterologists and Other Healthcare Professionals: Evidence from an Italian Survey.

作者信息

Marasco Giovanni, Bruni Angelo, Nardone Olga Maria, Lopetuso Loris Riccardo

机构信息

Division of Internal Medicine and Digestive Physiopathology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.

Department of Medical and Surgical Sciences, University of Bologna, 40138 Bologna, Italy.

出版信息

J Clin Med. 2024 Aug 13;13(16):4749. doi: 10.3390/jcm13164749.

DOI:10.3390/jcm13164749
PMID:39200891
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11355817/
Abstract

: Probiotics, which are live microorganisms that provide health benefits, have been extensively studied for their various clinical applications. However, despite their potential, high-quality data supporting their use in several gastrointestinal diseases are often lacking, and prescription behaviors can widely differ. This study aimed to assess different behaviors in probiotics knowledge and prescriptions among Italian gastroenterologists and healthcare professionals (HPs). : A web-based electronic survey was distributed to all participants at the National Meeting of the Italian Young Gastroenterologist and Endoscopist Association (AGGEI) held in 2023. The survey investigated probiotic prescription practices for several gastrointestinal conditions, such as acute diarrhea, irritable bowel syndrome, inflammatory bowel disease, and diverticular disease. : Among 200 participants, 142 completed the survey, of whom 59 were gastroenterologists and 83 were HPs (surgeons, nutrition biologists, and other physicians). Significant differences were observed in the prescription of probiotics for the treatment of acute diarrhea and . Both groups prescribed probiotics in monthly cycles for patients with IBS, although the majority prescribed multistrain formulations. Gastroenterologists were more likely to prescribe cyclic courses for IBS, while HPs tended to continue therapy by changing the probiotic strain in case of inefficacy. For ulcerative colitis, gastroenterologists prescribed probiotics more but for shorter durations. In Crohn's disease, gastroenterologists prescribed probiotics less and were less likely to prescribe multistrain formulations. Regarding SUDD, gastroenterologists tended to prescribe probiotics less frequently, although without a significant difference, with similar rates of preference for multistrain formulations. : This survey highlights heterogeneous behaviors in probiotic prescription between gastroenterologists and HPs, with gastroenterologists more aligned with guidelines and available scientific evidence. Hence, enhancing probiotic education among healthcare professionals and gastroenterologists is crucial. Further studies are needed to better understand probiotics' role in gastrointestinal disorders through large-scale randomized controlled trials.

摘要

益生菌是对健康有益的活微生物,其各种临床应用已得到广泛研究。然而,尽管它们具有潜力,但支持其用于多种胃肠道疾病的高质量数据往往缺乏,而且处方行为差异很大。本研究旨在评估意大利胃肠病学家和医疗保健专业人员(HPs)在益生菌知识和处方方面的不同行为。

一项基于网络的电子调查问卷被分发给参加2023年意大利年轻胃肠病学家和内镜医师协会(AGGEI)全国会议的所有参与者。该调查研究了几种胃肠道疾病的益生菌处方实践,如急性腹泻、肠易激综合征、炎症性肠病和憩室病。

在200名参与者中,1...完整翻译请参考:https://fanyi.baidu.com/?aldtype=16047#en/zh/%3A%20Probiotics%2C%20which%20are%20live%20microorganisms%20that%20provide%20health%20benefits%2C%20have%20been%20extensively%20studied%20for%20their%20various%20clinical%20applications.%20However%2C%20despite%20their%20potential%2C%20high-quality%20data%20supporting%20their%20use%20in%20several%20gastrointestinal%20diseases%20are%20often...

(你提供的原文中“Among 200 participants, 142 completed the survey, of whom 59 were gastroenterologists and 83 were HPs (surgeons, nutrition biologists, and other physicians). Significant differences were observed in the prescription of probiotics for the treatment of acute diarrhea and.”这段内容不完整,请补充完整后我再为你准确翻译。)

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/020e/11355817/48751902b175/jcm-13-04749-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/020e/11355817/bba363038810/jcm-13-04749-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/020e/11355817/4f0d84903586/jcm-13-04749-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/020e/11355817/48751902b175/jcm-13-04749-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/020e/11355817/bba363038810/jcm-13-04749-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/020e/11355817/4f0d84903586/jcm-13-04749-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/020e/11355817/48751902b175/jcm-13-04749-g003.jpg

相似文献

1
Insights into Probiotic Prescription among Gastroenterologists and Other Healthcare Professionals: Evidence from an Italian Survey.胃肠病学家和其他医疗保健专业人员对益生菌处方的见解:来自一项意大利调查的证据。
J Clin Med. 2024 Aug 13;13(16):4749. doi: 10.3390/jcm13164749.
2
Insights into Mesalazine Use in Clinical Practice of Young Gastroenterologists.青年胃肠病学家临床实践中使用美沙拉嗪的见解。
J Clin Med. 2023 Mar 2;12(5):2005. doi: 10.3390/jcm12052005.
3
Probiotic use in clinical practice: Results of a national survey of gastroenterologists and nutritionists.临床实践中益生菌的使用:一项针对胃肠病学家和营养学家的全国性调查结果。
Rev Gastroenterol Mex (Engl Ed). 2019 Jul-Sep;84(3):303-309. doi: 10.1016/j.rgmx.2018.05.004. Epub 2018 Jun 28.
4
Probiotics in the management of gastrointestinal disease: analysis of the attitudes and prescribing practices of gastroenterologists and surgeons.益生菌在胃肠道疾病管理中的应用:胃肠病学家和外科医生态度和处方实践的分析。
J Dig Dis. 2011 Dec;12(6):489-96. doi: 10.1111/j.1751-2980.2011.00534.x.
5
[Diverticular disease: treatment and management by general practitioners in Germany - high importance of probiotics in primary care].[憩室病:德国全科医生的治疗与管理——益生菌在初级保健中的高度重要性]
MMW Fortschr Med. 2022 Dec;164(Suppl 8):16-26. doi: 10.1007/s15006-022-2072-8.
6
Efficacy, Safety, and Concerns on Microbiota Modulation, Antibiotics, Probiotics, and Fecal Microbial Transplant for Inflammatory Bowel Disease and Other Gastrointestinal Conditions: Results from an International Survey.关于微生物群调节、抗生素、益生菌和粪便微生物移植用于炎症性肠病及其他胃肠道疾病的疗效、安全性和相关问题:一项国际调查的结果
Microorganisms. 2023 Nov 19;11(11):2806. doi: 10.3390/microorganisms11112806.
7
A Mini Literature Review of Probiotics: Transforming Gastrointestinal Health Through Evidence-Based Insights.益生菌的小型文献综述:通过循证见解改善胃肠道健康
Cureus. 2024 Mar 27;16(3):e57055. doi: 10.7759/cureus.57055. eCollection 2024 Mar.
8
British Dietetic Association systematic review of systematic reviews and evidence-based practice guidelines for the use of probiotics in the management of irritable bowel syndrome in adults (2016 update).英国饮食协会对成人肠易激综合征管理中使用益生菌的系统评价的系统评价及循证实践指南(2016年更新)
J Hum Nutr Diet. 2016 Oct;29(5):576-92. doi: 10.1111/jhn.12386. Epub 2016 Jun 6.
9
How patients view probiotics: findings from a multicenter study of patients with inflammatory bowel disease and irritable bowel syndrome.患者如何看待益生菌:一项炎症性肠病和肠易激综合征患者多中心研究的结果。
J Clin Gastroenterol. 2012 Feb;46(2):138-44. doi: 10.1097/MCG.0b013e318225f545.
10
Probiotics in Gastrointestinal Diseases: All that Glitters Is Not Gold.胃肠道疾病中的益生菌:并非所有闪光的都是金子。
Dig Dis. 2022;40(1):123-132. doi: 10.1159/000516023. Epub 2021 Mar 22.

本文引用的文献

1
Microbiota modulation in disorders of gut-brain interaction.肠道-脑相互作用障碍中的微生物群调节。
Dig Liver Dis. 2024 Dec;56(12):1971-1979. doi: 10.1016/j.dld.2024.05.004. Epub 2024 May 20.
2
Probiotics in Infancy and Childhood for Food Allergy Prevention and Treatment.婴幼儿益生菌用于食物过敏预防和治疗。
Nutrients. 2024 Jan 18;16(2):297. doi: 10.3390/nu16020297.
3
Journal of Clinical Gastroenterology Lectureship Dubai 2022 : Management of Irritable Bowel Syndrome With Diarrhea.《临床胃肠病学杂志》2022年迪拜讲座:腹泻型肠易激综合征的管理
J Clin Gastroenterol. 2024 Mar 1;58(3):221-231. doi: 10.1097/MCG.0000000000001964.
4
as a predictive marker of response to probiotic treatment in non-constipated irritable bowel syndrome.作为非便秘型肠易激综合征益生菌治疗反应的预测标志物。
Gut Microbes. 2024 Jan-Dec;16(1):2298246. doi: 10.1080/19490976.2023.2298246. Epub 2024 Jan 4.
5
Gut microbiota signatures and modulation in irritable bowel syndrome.肠易激综合征中的肠道微生物群特征与调节
Microbiome Res Rep. 2022 Mar 5;1(2):11. doi: 10.20517/mrr.2021.12. eCollection 2022.
6
Efficacy of Probiotics in Irritable Bowel Syndrome: Systematic Review and Meta-analysis.益生菌治疗肠易激综合征的疗效:系统评价与荟萃分析
Gastroenterology. 2023 Nov;165(5):1206-1218. doi: 10.1053/j.gastro.2023.07.018. Epub 2023 Aug 3.
7
The role of microbiota and its modulation in colonic diverticular disease.肠道微生物群及其调节在结肠憩室病中的作用。
Neurogastroenterol Motil. 2023 Dec;35(12):e14615. doi: 10.1111/nmo.14615. Epub 2023 May 27.
8
Inflammatory Bowel Diseases and Gut Microbiota.炎症性肠病与肠道微生物群。
Int J Mol Sci. 2023 Feb 14;24(4):3817. doi: 10.3390/ijms24043817.
9
Italian guidelines for the management of irritable bowel syndrome: Joint Consensus from the Italian Societies of: Gastroenterology and Endoscopy (SIGE), Neurogastroenterology and Motility (SINGEM), Hospital Gastroenterologists and Endoscopists (AIGO), Digestive Endoscopy (SIED), General Medicine (SIMG), Gastroenterology, Hepatology and Pediatric Nutrition (SIGENP) and Pediatrics (SIP).意大利肠易激综合征管理指南:来自意大利胃肠病学与内镜学会(SIGE)、神经胃肠病学与动力学会(SINGEM)、医院胃肠病学家与内镜医师学会(AIGO)、消化内镜学会(SIED)、普通医学学会(SIMG)、胃肠病学、肝病学与儿科营养学会(SIGENP)以及儿科学会(SIP)的联合共识
Dig Liver Dis. 2023 Feb;55(2):187-207. doi: 10.1016/j.dld.2022.11.015. Epub 2022 Dec 11.
10
Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility.功能性肠病伴腹泻:欧洲胃肠病学联合会和欧洲神经胃肠病学和动力学会临床指南。
United European Gastroenterol J. 2022 Jul;10(6):556-584. doi: 10.1002/ueg2.12259. Epub 2022 Jun 13.